Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
Saved in:
| Title: | Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer. |
|---|---|
| Authors: | Shore ND; Carolina Urologic Research Center, 823 82nd Pkwy, Suite B, Myrtle Beach, SC, 29572, USA. NShore@gsuro.com., Mehlhaff BA; Oregon Urology Institute, Springfield, OR, USA., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Saltzstein DR; Urology San Antonio, San Antonio, TX, USA., Tutrone R; Chesapeake Urology, Towson, MD, USA., Brown B; Myovant Sciences, Inc., Brisbane, CA, USA., Lu S; Myovant Sciences, Inc., Brisbane, CA, USA., Fallick M; Myovant Sciences, Inc., Brisbane, CA, USA., Hanson S; Pfizer Inc., New York, NY, USA., Saad F; University of Montreal Hospital Centre, Montreal, QC, Canada. |
| Source: | Advances in therapy [Adv Ther] 2023 Nov; Vol. 40 (11), pp. 4919-4927. Date of Electronic Publication: 2023 Sep 15. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1865-8652 |
|---|---|
| DOI: | 10.1007/s12325-023-02634-7 |
